AEGiS-WSJ: Revlon Gets FDA Clearance For New Drug, Factorate Wall Street JournalImportant note: Information in this article was accurate in 1984. The state of the art may have changed since the publication date.
Click here to return to Wall Street Journal main menu




DonateNow



Revlon Gets FDA Clearance For New Drug, Factorate

The Wall Street Journal - 16 February 1984

NEW YORK -- Revlon Inc. said it received Food and Drug Administration clearance to sell its new drug, heat-treated Factorate, for bleeding associated with hemophilia A.

Factorate concentrates are derived from human plasma and manufactured by a Revlon subsidiary, Armour Pharmaceutical Co., Tarrytown, N. Y. Revlon said it plans to begin selling Factorate within the next several weeks.

Revlon said the heat-treated Factorate is intended to reduce the possibility of the transmission of viruses, including hepatitis and acquired immune deficiency syndrome, or AIDS, a risk frequently encountered with coagulation drugs.

Revlon makes cosmetics, fragrances and pharmaceuticals.


840216
WJ840201

Copyright © 1984 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1984. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1984. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .